MENU
+Compare
TCRX
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$2.17
Change
-$0.02 (-0.91%)
Capitalization
122.62M

TCRX TScan Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for TCRX with price predictions
Feb 20, 2025

TCRX's RSI Oscillator ascending out of oversold territory

The RSI Indicator for TCRX moved out of oversold territory on February 19, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for TCRX just turned positive on February 19, 2025. Looking at past instances where TCRX's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TCRX advanced for three days, in of 173 cases, the price rose further within the following month. The odds of a continued upward trend are .

TCRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on February 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TCRX as a result. In of 62 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TCRX entered a downward trend on February 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.535) is normal, around the industry mean (12.644). P/E Ratio (0.000) is within average values for comparable stocks, (84.748). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.591). TCRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (24.450) is also within normal values, averaging (254.739).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TCRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TCRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TCRX is expected to report earnings to rise 17.00% to -29 cents per share on March 05

TScan Therapeutics TCRX Stock Earnings Reports
Q4'24
Est.
$-0.29
Q3'24
Beat
by $0.06
Q2'24
Est.
$-0.28
Q1'24
Missed
by $0.06
Q4'23
Beat
by $0.08
The last earnings report on November 12 showed earnings per share of -25 cents, beating the estimate of -31 cents. With 513.67K shares outstanding, the current market capitalization sits at 122.62M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
830 Winter Street
Phone
+1 857 399-9500
Employees
154
Web
https://www.tscan.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSTXF0.680.06
+9.18%
Heliostar Metals Ltd.
SBGSY53.161.62
+3.14%
Schneider Electric SE
SOUHY11.900.35
+3.03%
South32 Ltd.
FUPBY12.300.08
+0.63%
FUCHS SE
VWSYF13.690.03
+0.22%
Vestas Wind Systems A/S

TCRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with CRVO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then CRVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
+5.29%
CRVO - TCRX
42%
Loosely correlated
+1.09%
IMNM - TCRX
40%
Loosely correlated
+2.12%
SYRE - TCRX
40%
Loosely correlated
+0.18%
FATE - TCRX
39%
Loosely correlated
-9.65%
PRME - TCRX
39%
Loosely correlated
-4.72%
More